University of Cincinnati Cancer Institute — Cincinnati, Ohio

University of Cincinnati Cancer Institute is a clinical research site located in Cincinnati, Ohio, United States 45069.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Cincinnati Cancer Institute has participated in 40 clinical trials with 6 currently active.

Therapeutic areas: Squamous Cell Carcinoma of the Oropharynx, HPV16 Positive, Urothelial Carcinoma.

Sponsors: ISA Pharmaceuticals, Nabil Adra, Cornerstone Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Cincinnati Cancer Institute?

University of Cincinnati Cancer Institute has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Cincinnati Cancer Institute conducted?

University of Cincinnati Cancer Institute has 40 clinical trials on record, with 6 currently active. Their work covers Squamous Cell Carcinoma of the Oropharynx, HPV16 Positive, Urothelial Carcinoma.

Is University of Cincinnati Cancer Institute accredited by Crixeo Health?

Yes — University of Cincinnati Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Cincinnati Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.